Effects of a Pioglitazone/Metformin Fixed Combination in Comparison to Metformin in Combination With Glimepiride on Diabetic Dyslipidemia.
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Glimepiride; Metformin; Metformin/pioglitazone
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Takeda Pharma
- 10 Jun 2017 Biomarkers information updated
- 26 Jun 2010 Results presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 26 Jun 2010 Inflammatory marker results presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History